Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19
- Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION an CDC
- Monovalent XBB.1.5 vaccine shows 51% protection against COVID hospitalization University of Minnesota Twin Cities
- Updated COVID-19 Vaccination Effective Against ED/Urgent Care Encounters HealthDay
- Study: COVID-19 booster halves risk of moderate or severe disease in adults WSAW
- The fall COVID-19 shot’s effectiveness, and other respiratory virus news this week The Globe and Mail
Read More: Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19